Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-10-13, Stock:JNJ, The news for the past five days is as follows:
2021-10-06: NEWS1: Mixing & matching covid boosters ‘might be a great opportunity’: Doctor.NEWS2: Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna’s revenue next year.NEWS3: Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature.NEWS4: Moderna (MRNA) Gets EMA Authorization for SpikeVax Third Dose.NEWS5: J&J (JNJ) Seeks FDA Authorization for COVID-19 Booster Jab.NEWS6: Shares of Vaccine Makers Continue to Reel Under Merck’s Covid Drug Potential.NEWS7: The Energy Price Surge Is Spiraling Into Other Markets.NEWS8: J & J Applies for Emergency Use Authorization for COVID-19 Booster.NEWS9: J & J Applies for Emergency Use Authorization for COVID-19 Booster.NEWS10: Where can Investors Find Value in a Well-Rounded Company like Johnson & Johnson (NYSE:JNJ).
2021-10-07: NEWS1: Booster discussion 'a bit convoluted': Doctor.NEWS2: 'Administrative hurdles' could delay pediatric vaccine distribution: Doctor.NEWS3: 'Vaccine mandates are proving to work’: Doctor on Covid-19.NEWS4: 10 Dividend Stocks to Increase Your Monthly Income.NEWS5: What Do Mix-and-Match Doses Mean for Vaccine Stocks?.
2021-10-08: NEWS1: Studies claim Pfizer vaccine is less effective after a few months.NEWS2: Covid-19 Vaccine Boosters Are Outpacing First Doses. What Vaccine Stocks Are Doing..NEWS3: Covid-19 Vaccine Boosters Now Outpace First Doses, CDC Data Show.NEWS4: Johnson & Johson Asks FDA for Wider Use of Juvenile Arthritis Drug.NEWS5: 10 Boring Stocks That Make Money.NEWS6: 10 Best Big Pharma Stocks to Buy Now.NEWS7: COVID Update: Vaccine Booster Shots, Alternate Treatments Wrap Up.
2021-10-11: NEWS1: International SOS SVP details where doctors have been needed most.NEWS2: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference.NEWS3: Coronavirus: Doctor quotes Yogi Berra to urge everyone to 'let the data sort itself out'.NEWS4: J&J (JNJ) Seeks Stelara Label Expansion in Juvenile Arthritis.NEWS5: What Lies Ahead for Dow ETFs in Q3 Earnings?.NEWS6: Merck seeks emergency authorization for COVID pill.
2021-10-12: NEWS1: Breaking down the legality of workplace vaccine mandates.NEWS2: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS3: eMed CEO discusses what's next for COVID-19 testing.NEWS4: Dow Jones Leads Major Indexes Lower, But These Growth Stocks Soar.NEWS5: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations.NEWS6: Dow Jones Slips Ahead Of Bank Earnings; IBD 50 Jumps As Growth Stocks Rally.NEWS7: Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth.NEWS8: Pushing back on businesses’ ability to have a vaccine mandate is a bad idea: Doctor.NEWS9: J&J's Stoffels, who managed development of the company's COVID-19 shot, is retiring.NEWS10: UPDATE 3-U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boosters.NEWS11: 12 Best Long-Term Dividend Stocks To Buy Now.NEWS12: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire,  Effective December 31, 2021.NEWS13: 3 Dividend Stocks That Should Pay You for the Rest of Your Life.NEWS14: Johnson & Johnson's Top Scientist, Stoffels, to Retire at Year-End.NEWS15: FDA Advisory Panel Will Debate J&J and Moderna Boosters This Week.

Answer: Rise